Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
amitriptyline hydrochloride, Quantity: 25 mg
Ipca Pharma (Australia) Pty Ltd
amitriptyline hydrochloride
Tablet
Excipient Ingredients: titanium dioxide; hypromellose; magnesium stearate; quinoline yellow aluminium lake; lactose monohydrate; purified talc; macrogol 6000; maize starch; colloidal anhydrous silica; microcrystalline cellulose; crospovidone
Oral
20, 50 and 100
(S4) Prescription Only Medicine
For the treatment of major depression. Amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,Nocturnal enuresis where organic pathology has been excluded.
Visual Identification: Yellow colour, circular, biconvex, film coated tablets with 'IA' over '25' debossed on one side and plain on the other side; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2014-08-22